October 10, 2016
Emily Law and colleagues demonstrate the role of APOBEC3B in cancer drug resistance in the article "The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer" published in Science Advances.
September 21, 2016
A new paper by PhD. student Gabriel Starrett titled, "The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis," published in Nature Communications reveals a novel source of mutation in cancer. Links for press release: UMN News, Nature Communications
The Harris lab welcomes two new members, Drs. Teneale Stewart and Rena Levin-Klein!